Anualidad
Event
Entity
Process
Conference
Occurrent
11TH INTERNATIONAL CONFERENCE ON THROMBOSIS AND HEMOSTASIS ISSUES IN CANCER
Effectiveness and safety of 6-months¿ treatment with different full-dose enoxaparin regimens in patients with cancer-associated venous thromboembolism: a subgroup analysis of the RIETECAT cohort study.
Effectiveness and safety of enoxaparin in the extended treatment of venous thromboembolism in active cancer patients with renal impairment - Results from the RIETECAT-RI cohort study
RDF description of 11TH INTERNATIONAL CONFERENCE ON THROMBOSIS AND HEMOSTASIS ISSUES IN CANCER - http://research.umh.es/vivo/pub/congreso/133277